# James D. Marks

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-d-marks/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,728 |
| Field | Monoclonal and Polyclonal Antibodies Research |
| h-index | 76 |
| i10-index | 192 |
| Last Known Institution | San Francisco General Hospital |
| OpenAlex ID | https://openalex.org/A5038349275 |
| ORCID iD | https://orcid.org/0000-0003-0562-3517 |
| Works | 346 |

## Researcher papers

- [Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.](https://scholariq.org/papers/anti-her2-immunoliposomes-enhanced-efficacy-attributable-to-targeted-delivery/)

## Researcher topics

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)
- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [San Francisco General Hospital](https://scholariq.org/institutions/san-francisco-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.